RootK Co. Ltd.

RootK Co. Ltd.

KKRX:195990
1,140.00
KRW
-19.00
(-1.64%)
-397.92EPS
22.18BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
29,928.23
24,016.6
68,568.66
12,462.68
14,797.21
4,891.58
3,362.89
2,625.16
1,648.5
1,823.85
2,224.39
2,242.69
2,425.13
Basic EPS, GAAP
5,133.33
4,678.99
24
-3,153.6
-2,780
-5,801.4
-5,540
-800
-607.2
-1,850.2
-1,098
-3,436.8
-397.92
Free Cash Flow per Basic Share
-8,977.53
-902.7
-17,188.19
-10,036.78
289.67
-40.68
197.95
-479.09
-1,104.2
-510.38
-1,607.47
-631.24
-558.26
Dividend per Share
943.69
1,071.82
4,477.47
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
20,705.87
29,972.16
29,840.48
26,464.14
21,709.86
13,288.49
11,063.08
10,571.85
10,244.93
8,594.71
7,588.09
3,795.65
3,180.9
Tangible Book Value per Share
20,652.67
29,836.51
29,669.29
24,016.56
17,228.5
11,917.71
11,023.31
10,293.5
10,070.43
7,787.79
6,405.48
2,940.91
2,443.22
Basic Weighted Avg Shares
3
3
1
4
4
7
11
13
13
14
14
14
13
Sales/Revenue/Turnover
85,999
77,101
49,521
45,944
58,857
31,930
35,797
32,914
22,112
25,375
31,663
31,923
30,839
Operating Margin (%)
19.94
16.48
2.12
-25.4
-7.04
-93.53
-5.22
-12.73
-45.06
-34.71
-20.55
-29.06
-31.98
Depreciation Expense
831
1,518
1,776
3,336
6,000
4,463
7,248
2,625
1,402
1,870
1,484
1,694
1,704
Net Income, GAAP
14,751
15,021
17
-11,626
-11,058
-37,869
-58,972
-10,030
-8,145
-25,742
-15,629
-48,920
-5,060
Effective Tax Rate (%)
18.07
18.81
126.47
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
17.15
19.48
0.04
-25.3
-18.79
-118.6
-164.74
-30.47
-36.83
-101.44
-49.36
-153.24
-16.41
Working Capital
56,979
92,997
57,642
8,540
6,801
17,160
46,414
52,143
29,783
29,108
27,966
18,603
20,272
LT Debt
22,429
22,429
5,720
6,449
4,191
14,387
8,705
583
441
1,844
11,963
12,288
12,015
Total Equity
66,791
103,843
114,227
102,068
115,578
119,188
138,198
137,541
140,196
122,340
108,012
54,029
51,792
Return on Invested Capital (%)
- -
9.07
-0.2
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
13.89
-0.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
17.67
0.02
-11.22
-10.81
-33.76
-45.97
-7.25
-5.87
-19.61
-13.57
-60.38
-8.87

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
3,216
3,049
6,259
LT Borrowings
11,914
11,872
11,840
LT Finance Leases
374
206
175
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
16
16
Market Capitalization
74,019
46,437
22,176

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
26,993
32,041
32,118
Cash, Cash Equivalents & STI
5,082
5,997
11,950
Accounts Receivable, Net
3,689
6,190
6,616
Inventories
13,563
14,080
11,691
Total Current Liabilities
8,390
10,156
11,847
Payables & Accruals
- -
- -
- -
ST Debt
3,216
3,049
6,259
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-4.13%
-14.6%
-49.98%
Free Cash Flow
-72.24%
-25.81%
-60.73%
Net Income, GAAP
-6,669.17%
57.6%
213%
Sales/Revenue/Turnover
-4.9%
-0.1%
0.82%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,105
1,958
13,276
10,324
31,663
2025
8,872
9,117
7,871
6,064
31,923
2026
7,886
9,019
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-50.8
-84.2
596
-1,558.93
-1,098
2025
-114.55
-62,343.6
-14.48
-75.97
-3,436.8
2026
145.44
-718.06
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Yong-Un Kim
Full Time Employees
43
Sector
Producer manufacturing
Industry
Industrial machinery
Address
Daegu South Korea
IPO Date
Apr 13, 2015
Business
RootK Co., Ltd., formerly known as Abpro Bio Co., Ltd., is a South Korea-based company primarily engaged in the manufacturing of precision machine tools and the research and development of biopharmaceutical therapeutics. The company operates through two core business divisions: Machine Tools and Biotechnology. Its machine tools portfolio encompasses high-precision computer numerical control (CNC) tapping centers; vertical and horizontal machining centers; high-speed spindle machinery; CNC turning centers; and customized industrial processing equipment utilized in the manufacturing of consumer electronics, telecommunications devices, automotive parts, and precision engineered components. In its biotechnology segment, the company engages in the research and development of bispecific antibody platforms and therapeutic candidates targeting oncology and ophthalmology indications; its clinical-stage and preclinical pipeline includes bispecific antibody candidates for HER2-positive breast and gastric cancers (ABP-100), liver oncology treatments, and therapies for retinal vascular conditions such as diabetic macular edema and wet age-related macular degeneration (ABP-201). The company supplies industrial machinery domestically and to international manufacturing markets across Asia, while managing regional clinical development and commercialization rights for biotherapeutic programs in collaboration with U.S.-based Abpro Corporation. In recent developments, the company officially rebranded and changed its corporate name from Abpro Bio Co., Ltd. to RootK Co., Ltd. in June 2026 following shareholder approval, reflecting a broader strategic reorganization. Alongside this rebranding, the company amended its corporate charter to authorize new business expansions into digital media production, logistics services, and advertising sectors to diversify its revenue streams while sustaining core engineering operations and therapeutic development programs. Founded in 2004, RootK Co., Ltd. is headquartered in Daegu, South Korea, and is listed on the KOSDAQ market of the Korea Exchange under ticker 195990.